Related Experiment Video
Updated: Jun 20, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy
Yundi Chen1,2, Shasha Tang1, Fengfeng Cai1
1Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Research (Washington, D.C.)
|July 23, 2024
Summary
Extracellular vesicles (EVs) are key to cell communication and show promise in cancer research. This review explores EV-based cancer immunotherapy strategies to overcome clinical translation challenges.
Area of Science:
- Cell Biology
- Immunology
- Biotechnology
Background:
- Extracellular vesicles (EVs) are cell-released vesicles mediating intercellular communication.
- EVs carry cellular cargo and are involved in physiological and pathological processes.
- EVs have potential clinical applications in drug delivery, therapeutics, and diagnostics.
Purpose of the Study:
- To review current strategies in EV-based cancer immunotherapy.
- To address challenges in the clinical translation of EV cancer immunotherapeutics.
- To advance the development of EV-based cancer immunotherapy.
Main Methods:
- Literature review of EV-based cancer immunotherapy strategies.
- Analysis of existing research in EV-focused cancer physiopathology, liquid biopsy, and drug delivery.
- Examination of cell and animal studies on EV immunotherapeutics.
Main Results:
- Significant progress has been made in EV-based cancer physiopathology, liquid biopsy, and drug delivery.
- The exploration of EVs as cancer immunotherapeutic agents requires further development.
- Promising findings in preclinical studies face challenges for clinical translation.
Conclusions:
- EVs are crucial mediators of intercellular communication with therapeutic potential.
- EV-based cancer immunotherapy is an emerging field with significant challenges.
- Further research and strategic development are needed to translate EV immunotherapeutics into clinical practice.
Related Concept Videos
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
01:30Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K